FIBROGEN INC's ticker is FGEN and the CUSIP is 31572Q808. A total of 194 filers reported holding FIBROGEN INC in Q2 2019. The put-call ratio across all filers is 1.48 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $8,086,000 | +13.7% | 148,780 | -3.1% | 0.03% | +3.8% |
| Q4 2018 | $7,109,000 | -77.1% | 153,617 | -69.9% | 0.03% | -69.8% |
| Q3 2018 | $31,051,000 | -19.9% | 511,120 | -17.5% | 0.09% | -23.9% |
| Q2 2018 | $38,781,000 | +44.9% | 619,500 | +6.9% | 0.11% | +43.0% |
| Q1 2018 | $26,763,000 | +23.0% | 579,289 | +26.2% | 0.08% | +27.4% |
| Q4 2017 | $21,758,000 | -21.2% | 459,031 | -10.6% | 0.06% | -23.5% |
| Q3 2017 | $27,628,000 | – | 513,523 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vantage Consulting Group Inc | 605,713 | $7,880,000 | 4.60% |
| ARMISTICE CAPITAL, LLC | 4,456,000 | $57,973,000 | 1.01% |
| Intercontinental Wealth Advisors, LLC | 191,300 | $2,489,000 | 0.78% |
| BHK Investment Advisors, LLC | 87,450 | $1,138,000 | 0.57% |
| Soleus Capital Management, L.P. | 234,026 | $3,045,000 | 0.41% |
| Tri Locum Partners LP | 74,348 | $967,000 | 0.26% |
| Point72 Asset Management, L.P. | 4,777,700 | $62,158,000 | 0.25% |
| PRIMECAP MANAGEMENT CO/CA/ | 13,179,897 | $171,470,000 | 0.17% |
| Newbridge Financial Services Group, Inc. | 20,285 | $264,000 | 0.16% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 1,430,526 | $18,611,000 | 0.15% |